Recent Quotes (30 days)

You have no recent quotes
chg | %

Shire PLC news

   Watch this stock
Showing stories 1 - 10 of about 110   

Articles published

SHP 4,664.00 +35.00 (0.76%)
price chart
Is It Too Late To Buy Shire PLC, Hikma Pharmaceuticals Plc and SkyePharma ...
Shire has an attractive 37% operating margin, minimal debt, and generates a lot of free cash flow, which it can use to fund R&D and shareholder returns.
Related articles »  
Why Shire PLC Has Beaten AstraZeneca plc And GlaxoSmithKline plc In 2014
If you invest in pharmaceuticals, Shire (LSE: SHP) is the one you should have bought this year. It's up 60% in the past 12 months to 4,395p, easily beating the FTSE 100's big two - AstraZeneca (LSE: AZN) (NYSE: AZN.
GlaxoSmithKline plc Earns "Neutral" Rating from JPMorgan Chase ...  Ticker Report
Related articles »  
Shire Plc (SHPG) Weighing Bid For NPS Pharmaceuticals (NPSP)
Irish-headquartered Shire plc (NASDAQ:SHPG) is said to be interested in acquiring US-based biotech NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) in an attempt to expand its reach in rare diseases such as gastrointestinal and endocrine disorders, ...
Shire considering bid for NPS Pharmaceuticals - Bloomberg  Reuters UK
Shire Considers Bid For NPS Pharma : Report  Nasdaq
Related articles »  
Why the Earnings Streak Will Continue for Shire plc (SHPG) - Tale of the Tape
Looking for a stock that might be in a good position to beat earnings at its next report? Consider Shire plc ( SHPG ), a firm in the Medicine-Drugs industry, which could be a great candidate for another beat.
NPS Pharmaceuticals (NPSP) Jumps: Stock Moves 18.5% Up  Zacks.com
Related articles »  
Shire PLC's CEO eyes deals, but no urgency to spend AbbVie breakup fee
NEW YORK: Shire PLC's chief executive said he sees no urgency to spend the windfall the Dublin-based drugmaker received when AbbVie walked away from a $55 billion takeover bid earlier this year.
Shire CEO eyes deals, but no urgency to spend AbbVie breakup fee  Reuters
Shire PLC (SHPG) Unveils Plans To Add $3 Billion In Product Sales By 2020  Bidness ETC
Related articles »  
Credit Suisse Reiterates �Neutral� Rating for Shire PLC (SHP)
Shire PLC logo Shire PLC (LON:SHP)'s stock had its �neutral� rating restated by stock analysts at Credit Suisse in a report issued on Thursday.
Shire PLC Stock Rating Reaffirmed by Deutsche Bank (SHPGY)  WKRB News
Shire PLC Receives Buy Rating from Jefferies Group (SHPGY)  Ticker Report
Related articles »  
Shire PLC Downgraded by Bank of America to "Neutral" (SHP)
Shire PLC logo Bank of America cut shares of Shire PLC (LON:SHP) to a neutral rating in a research note issued to investors on Tuesday.
Shire PLC Rating Reiterated by JPMorgan Chase & Co. (SHP)  WKRB News
Shire PLC Given "Overweight" Rating at JPMorgan Chase & Co. (SHP)  The Legacy
Related articles »  
Monday Moving Stocks: ResMed Inc. (RMD), Shire plc (SHPG), Nordstrom Inc ...
Shire plc (SHPG) of the Drug Manufacturers - Major sector ended last week at $216.73, a loss of -1.88% and return on investment of 27.10%, trading at a volume of 1,113,724 shares.
Shire PLC Earns "Buy" Rating from Deutsche Bank (SHPGY)
Shire PLC logo Shire PLC (NASDAQ:SHPGY)'s stock had its �buy� rating restated by Deutsche Bank in a research note issued on Friday.
Shire PLC Receives Consensus Recommendation of "Buy" from Brokerages ...
Shire PLC logo Shire PLC (NASDAQ:SHPG) has received an average recommendation of �Buy� from the twenty-one ratings firms that are covering the stock, Analyst Ratings Network.
Shire PLC Given New GBX 5200 Price Target at Morgan Stanley (SHP)  WKRB News
Shire PLC Given Consensus Rating of "Buy" by Brokerages (LON:SHP)  Mideast Time
Related articles »